Multi-gene Panel Testing Confirms Phenotypic Variability in MUTYH-Associated Polyposis

Overview

Journal Fam Cancer

Publisher Springer

Specialty Oncology

Date 2019 Jan 4

PMID 30604180

Citations 17

Authors

Erin G Sutcliffe

Amanda Bartenbaker Thompson

Amy R Stettner

Megan L Marshall

Maegan E Roberts

Lisa R Susswein

Ying Wang

Rachel T Klein

Kathleen S Hruska

Benjamin D Solomon

Affiliations

Soon will be listed here.

Abstract

Biallelic pathogenic variants (PVs) in MUTYH cause MUTYH-Associated Polyposis (MAP), which displays phenotypic overlap with other hereditary colorectal cancer (CRC) syndromes including Familial Adenomatous Polyposis (FAP) and Lynch syndrome. We report the phenotypic spectrum of MAP in the context of multi-gene hereditary cancer panel testing. Genetic testing results and clinical histories were reviewed for individuals with biallelic MUTYH PVs detected by panel testing at a single commercial molecular diagnostic laboratory. Biallelic MUTYH PVs were identified in 82 individuals (representing 0.2% of tested individuals) with most (75/82; 91.5%) reporting a personal history of CRC and/or polyps. Ten percent (6/61) of individuals reporting polyp number reported fewer than 10 polyps and therefore did not meet current MAP testing criteria. Extracolonic cancers (21/82; 25.6%), multiple primaries (19/82; 23.2%), Lynch-like (17/82; 20.7%) and FAP-like phenotypes (16/82; 19.5%) were observed, including individuals with mismatch repair-deficient tumors (3/82; 3.7%), sebaceous neoplasms (2/82; 2.4%), or congenital hypertrophy of the retinal pigment epithelium (CHRPE) (2/82; 2.4%). We report what is to our knowledge the first cohort of individuals with MAP identified by panel testing. The phenotypic spectrum of MAP observed in this cohort aligns with the published literature. In addition to standard indications for MUTYH testing, our data provide evidence to support consideration of MAP in the differential diagnosis for some individuals with fewer than 10 polyps, depending on other personal and/or family history, as well as for individuals suspected to have Lynch syndrome or FAP.

Citing Articles

Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint....

Zaffaroni G, Mannucci A, Koskenvuo L, de Lacy B, Maffioli A, Bisseling T Br J Surg. 2024; 111(5).

PMID: 38722804 PMC: 11081080. DOI: 10.1093/bjs/znae070.

A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America.

Esperon P, Neffa F, Pavicic W, Spirandelli F, Alvarez K, Mullins M Fam Cancer. 2024; 23(4):507-513.

PMID: 38687439 DOI: 10.1007/s10689-024-00382-3.

associated polyposis: Is it time to change upper gastrointestinal surveillance? A single-center case series and a literature overview.

Sanchez-Mete L, Mosciatti L, Casadio M, Vittori L, Martayan A, Stigliano V World J Gastrointest Oncol. 2023; 15(11):1891-1899.

PMID: 38077639 PMC: 10701228. DOI: 10.4251/wjgo.v15.i11.1891.

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.

Tung N, Dougherty K, Stern Gatof E, DeLeonardis K, Hogan L, Tukachinsky H NPJ Precis Oncol. 2023; 7(1):76.

PMID: 37568048 PMC: 10421918. DOI: 10.1038/s41698-023-00429-1.

Complete Response to Immunotherapy in a Patient with -Associated Polyposis and Gastric Cancer: A Case Report.

Mathias-Machado M, Peixoto R, Ashton-Prolla P, da Silva L, Dienstmann R Case Rep Oncol. 2023; 16(1):504-510.

PMID: 37469678 PMC: 10352934. DOI: 10.1159/000530965.

References

Landon M, Ceulemans S, Saraiya D, Strike B, Arnell C, Burbidge L . Analysis of current testing practices for biallelic MUTYH mutations in MUTYH-associated polyposis. Clin Genet. 2014; 87(4):368-72. DOI: 10.1111/cge.12375. View

Riegert-Johnson D, Johnson R, Rabe K, Wang L, Thomas B, Baudhuin L . The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing. Genet Test. 2008; 11(4):361-5. DOI: 10.1089/gte.2007.0014. View

Farrington S, Tenesa A, Barnetson R, Wiltshire A, Prendergast J, Porteous M . Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005; 77(1):112-9. PMC: 1226182. DOI: 10.1086/431213. View

Wallis Y, Macdonald F, Hulten M, Morton J, McKeown C, Neoptolemos J . Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet. 1994; 94(5):543-8. DOI: 10.1007/BF00211023. View

Susswein L, Marshall M, Nusbaum R, Postula K, Weissman S, Yackowski L . Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med. 2015; 18(8):823-32. PMC: 4985612. DOI: 10.1038/gim.2015.166. View

Jenkins M, Croitoru M, Monga N, Cleary S, Cotterchio M, Hopper J . Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev. 2006; 15(2):312-4. DOI: 10.1158/1055-9965.EPI-05-0793. View

Morak M, Laner A, Bacher U, Keiling C, Holinski-Feder E . MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations. Clin Genet. 2010; 78(4):353-63. DOI: 10.1111/j.1399-0004.2010.01478.x. View

Roberts M, Jackson S, Susswein L, Zeinomar N, Ma X, Marshall M . MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer. Genet Med. 2018; 20(10):1167-1174. PMC: 6051923. DOI: 10.1038/gim.2017.254. View

Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A . Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009; 137(6):1976-85.e1-10. DOI: 10.1053/j.gastro.2009.08.052. View

10.

Castillejo A, Vargas G, Castillejo M, Navarro M, Barbera V, Gonzalez S . Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. Eur J Cancer. 2014; 50(13):2241-50. DOI: 10.1016/j.ejca.2014.05.022. View

11.

Gismondi V, Meta M, Bonelli L, Radice P, Sala P, Bertario L . Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer. 2004; 109(5):680-4. DOI: 10.1002/ijc.20054. View

12.

Tricarico R, Bet P, Ciambotti B, Di Gregorio C, Gatteschi B, Gismondi V . Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations. Cancer Lett. 2008; 274(2):266-70. DOI: 10.1016/j.canlet.2008.09.022. View

13.

Win A, Reece J, Dowty J, Buchanan D, Clendenning M, Rosty C . Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer. 2016; 139(7):1557-63. PMC: 5094810. DOI: 10.1002/ijc.30197. View

14.

Goodenberger M, Lindor N . Lynch syndrome and MYH-associated polyposis: review and testing strategy. J Clin Gastroenterol. 2011; 45(6):488-500. DOI: 10.1097/MCG.0b013e318206489c. View

15.

Barnetson R, Devlin L, Miller J, Farrington S, Slater S, Drake A . Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin Genet. 2007; 72(6):551-5. DOI: 10.1111/j.1399-0004.2007.00900.x. View

16.

Sieber O, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips R . Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 2003; 348(9):791-9. DOI: 10.1056/NEJMoa025283. View

17.

Coleman P, Barnard N . Congenital hypertrophy of the retinal pigment epithelium: prevalence and ocular features in the optometric population. Ophthalmic Physiol Opt. 2007; 27(6):547-55. DOI: 10.1111/j.1475-1313.2007.00513.x. View

18.

Balaguer F, Castellvi-Bel S, Castells A, Andreu M, Munoz J, Gisbert J . Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol. 2007; 5(3):379-87. DOI: 10.1016/j.cgh.2006.12.025. View

19.

Morak M, Heidenreich B, Keller G, Hampel H, Laner A, de la Chapelle A . Biallelic MUTYH mutations can mimic Lynch syndrome. Eur J Hum Genet. 2014; 22(11):1334-7. PMC: 4200426. DOI: 10.1038/ejhg.2014.15. View

20.

Cleary S, Cotterchio M, Jenkins M, Kim H, Bristow R, Green R . Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009; 136(4):1251-60. PMC: 2739726. DOI: 10.1053/j.gastro.2008.12.050. View